Alpha-1 Suite, RCSI Building, Beaumont Hospital, Dublin 9, Ireland
Charity Number CHY22304
Site Developed & Maintained by Ecom-Ireland
2021 © Copyright Alpha-1 Foundation Ireland. All rights reserved.
Alpha-1 Suite, RCSI Building, Beaumont Hospital, Dublin 9, Ireland
Charity Number CHY22304
Site Developed & Maintained by Ecom-Ireland
2021 © Copyright Alpha-1 Foundation Ireland. All rights reserved.
Fourth International Alpha-1 Patient Congress April 11th 2013
Dear Friends of Alpha-1,
In April 1963, Swedish researchers Carl-Bertil Laurell and Sten Eriksson published their landmark research on the discovery of Alpha-1 Antitrypsin Deficiency. To commemorate the 50th anniversary of the discovery, the Fourth International Alpha-1 Patient Congress and an international Research Conference on Alpha-1 Antitrypsin Deficiency will be held in Barcelona, Spain, April 11th – 13th, 2013.
Alphas from all over the world are welcome to attend the Congress, and Alpha-1 patient associations from many countries are expected to send delegates. The Research Conference will be held April 11-12, and there will be a joint session of patients and scientists on the afternoon of Friday, April 12.
National Patient Associations can name two delegates per country as guests of the meeting organizer for two nights, with travel, hotel and meals included.
Please let me know who plans on attending from your Association. Log on to the conference website at www.alpha-1barcelona2013.org for further information.
Please also consider posting a story on your Associations website with a link to congress website.
Kind Regards,
Angela McBride
Steering Committee Barcelona Congress
Email: info@alpha-1barcelona2013.org
Info Centre
What is Alpha-1 Antitrypsin?
Alpha-1 antitrypsin is a vital protein produced by the liver to protect the lungs. It provides protection from the harmful effects of infections and inhaled irritants, particularly tobacco smoke. It can be easily measured by a simple blood test.
What is Alpha-1 Antitrypsin Deficiency?
Alpha-1 antitrypsin deficiency (Alpha-1) is a genetic condition which, after cystic fibrosis, is the commonest genetic disorder in Ireland. It severely affects more than 15,000 people, with another 250,000 carriers also at risk of lung and liver disease on the island of Ireland. It is a proven genetic risk factor for chronic obstructive pulmonary disease (COPD).
How Do I Get Tested?
The Alpha-1 Foundation Ireland provides free testing for Alpha-1 as part of a national screening programme which is funded by the HSE. It is a simple blood test. For more details ring 01-8093871 or email alpha1@rcsi.ie